Skip to content

Clinical trials

Phase 2 Depressive Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Depressive Disorder Phase: Phase 2 Clear all

84 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20033
20044
20052
20065
20073
20083
20092
20103
20122
20134
20141
20153
20175
20182
20196
20203
20211
20225
20237
20245
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed58
Recruiting8
Terminated6
Unknown status6
Withdrawn2
Enrolling by invitation2
Not yet recruiting1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Mental Health (NIMH)8
GlaxoSmithKline6
Vanderbilt University Medical Center3
Centre Hospitalier Universitaire de Besancon2
Clexio Biosciences Ltd.2
H. Lundbeck A/S2
Janssen Research & Development, LLC2
Lingjiang Li2
Marinus Pharmaceuticals2
Merck Sharp & Dohme LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Depressive Disorder84
Major Depressive Disorder40
Mood Disorders18
Bipolar Disorder9
Depressive Disorder, Treatment-Resistant9
Mental Disorders7
Anxiety Disorders6
Anhedonia2
Cognitive Dysfunction2
Depression, Postpartum2

Trials

Showing 26 to 50 of 84. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.